Anti-inflammatory composition for aiding and promoting the healing of chronic ulcerative lesions
AssigneePebisut De Mexico S.A. DE C.V.
InventorJorge Cueto Garcia
Life of this patent
Estimating the term…
Abstract
The invention relates to an anti-inflammatory composition comprising: 53 wt.-% maltodextrin in relation to the total weight; 10-12 wt.-% zinc oxide as a thixotropic agent; 1.8 wt.-% maltose; 0.0002 wt.-% sodium; 0.0002 wt.-% potassium; 0.0002 wt.-% calcium; 0.0002 wt.-% phosphor; and 0.0006 wt.-% magnesium. The composition has an application viscosity in the range of 12,000-33,000 cp, a pH of between 5.6 and 6.9, a TGA of 61.12 and bond strength at 24 hours of 6 MPa.
Claims6
An anti-inflammatory and bacteriostatic composition comprising 53% by weight of non-hygroscopic maltodextrin, from 8 to 12% by weight of zinc oxide as thixotropy agent, 1.8% by weight of maltose, 0.0002% by weight of sodium, 0.0002% by weight of potassium, 0.0002% by weight of calcium, 0.0002% by weight of phosphorus, and 0.0006% by weight of magnesium, and the remainder water, wherein the anti-inflammatory and bacteriostatic composition has a viscosity greater than 100,000 cp and a pH from 5.6 to 6.9 for use in the treatment of chronic ulcerated lesions of diabetic foot and varicose ulcers.
Dependencies are inferred from the claim text.